2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow SNF472: new trials by email Literature Review of SNF472 trials Research Report on SNF472
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of SNF472 on Progression of Cardiovascular Calcification in End-Stage-Renal-Disease (ESRD) Patients on Hemodialysis (HD) SNF472, Placebo - Cardiovascular Diseases, Cardiovascular Abnormalities | Phase 2 | Completed | Sanifit Therapeutics S. A. | 274 | 2016-11-01 | 2021-04-15 |
| Phase 2 Study With SNF472 in Calciphylaxis Patients SNF472 - Calciphylaxis, Calcific Uremic Arteriolopathy | Phase 2 | Completed | Sanifit Therapeutics S. A. | 14 | 2016-05-01 | 2019-08-28 |
Calcinosis (2) · Kidney Failure, Chronic (2) · Calciphylaxis (1) · Calcium Metabolism Disorders (1) · Cardiovascular Abnormalities (1) · Cardiovascular Diseases (1) · Metabolic Diseases (1) · Rare Diseases (1) · Vascular Calcification (1)
Sanifit Therapeutics S. A. (2)
United Kingdom (2) · United States (2) · Spain (1)
Alex Gold, MD (1) · Vincent Brandenburg (1)